Sponsor Pipeline

Apogee Therapeutics, Inc. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
4
Active Trials
1
Recruiting
2
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-07-30 NCT07003425
A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis		 Trial sites expanded: 63 -> 67 locations
Active Trials by Phase
Phase 2
2
Phase 1
2
Active Trials
NCT IDTitleConditionStatus
Phase 2
NCT07003425 A Long-term Safety and Efficacy Study Evaluating APG777 in Atopic Dermatitis Atopic Dermatitis Recruiting
NCT06395948 A Study Evaluating APG777 in Atopic Dermatitis Atopic Dermatitis Active, Not Recruiting
Phase 1
NCT06920901 A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity… Asthma Active, Not Recruiting
NCT07027527 An Active Comparator Safety Study Evaluating the Combination of APG777 + APG990 in… Atopic Dermatitis Active, Not Recruiting
Disease Areas
Atopic Dermatitis (3) Asthma (1)
Get alerts when Apogee Therapeutics, Inc.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free